Previous studies5,13 demonstrated that blocking the CB1 receptor by pharmacological antagonistslike RIM (SR141716A) or genetic inactivation like in Cnr1-/- mice limited theprogression of hepatic fibrosis whether the fibrosis was induced by bile ductligation, CCL4 or thioacetamide. The gene discussed is CCL4; the disease is Hepatic fibrosis.